Cambridge Investment Research Advisors’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.4M | Buy |
69,165
+6,366
| +10% | +$1.32M | 0.04% | 485 |
|
|
2026
Q1 | $13.3M | Buy |
62,799
+23,611
| +60% | +$5.08M | 0.03% | 510 |
|
|
2025
Q4 | $8.05M | Buy |
39,188
+3,333
| +9% | +$627K | 0.02% | 675 |
|
|
2025
Q3 | $5.63M | Buy |
35,855
+1,558
| +5% | +$241K | 0.02% | 847 |
|
|
2025
Q2 | $5.76M | Buy |
34,297
+1,184
| +4% | +$176K | 0.02% | 780 |
|
|
2025
Q1 | $4.56M | Sell |
33,113
-59
| -0.2% | -$7.52K | 0.02% | 855 |
|
|
2024
Q4 | $3.92M | Sell |
33,172
-7,853
| -19% | -$917K | 0.01% | 938 |
|
|
2024
Q3 | $4.53M | Sell |
41,025
-21,728
| -35% | -$2.27M | 0.02% | 850 |
|
|
2024
Q2 | $6.17M | Buy |
62,753
+3,158
| +5% | +$322K | 0.02% | 659 |
|
|
2024
Q1 | $6.67M | Sell |
59,595
-9,828
| -14% | -$1.06M | 0.03% | 609 |
|
|
2023
Q4 | $7M | Buy |
69,423
+32,250
| +87% | +$3.2M | 0.03% | 555 |
|
|
2023
Q3 | $3.23M | Buy |
37,173
+2,024
| +6% | +$183K | 0.02% | 886 |
|
|
2023
Q2 | $3.32M | Buy |
35,149
+1,517
| +5% | +$128K | 0.02% | 871 |
|
|
2023
Q1 | $2.54M | Sell |
33,632
-2,767
| -8% | -$209K | 0.01% | 997 |
|
|
2022
Q4 | $2.8M | Buy |
36,399
+7,924
| +28% | +$602K | 0.01% | 899 |
|
|
2022
Q3 | $1.9M | Sell |
28,475
-3,094
| -10% | -$196K | 0.01% | 1067 |
|
|
2022
Q2 | $1.65M | Buy |
31,569
+2,938
| +10% | +$167K | 0.01% | 1142 |
|
|
2022
Q1 | $1.62M | Buy |
28,631
+4,468
| +18% | +$239K | 0.01% | 1267 |
|
|
2021
Q4 | $1.24M | Buy |
24,163
+314
| +1% | +$15.4K | 0.01% | 1436 |
|
|
2021
Q3 | $1.18M | Buy |
23,849
+392
| +2% | +$21.3K | 0.01% | 1406 |
|
|
2021
Q2 | $1.34M | Sell |
23,457
-1,236
| -5% | -$72.2K | 0.01% | 1335 |
|
|
2021
Q1 | $1.5M | Sell |
24,693
-59
| -0.2% | -$3.26K | 0.01% | 1177 |
|
|
2020
Q4 | $1.33M | Buy |
24,752
+3,160
| +15% | +$164K | 0.01% | 1142 |
|
|
2020
Q3 | $1.01M | Buy |
21,592
+1,225
| +6% | +$62.9K | 0.01% | 1183 |
|
|
2020
Q2 | $1.06M | Buy |
20,367
+8,861
| +77% | +$457K | 0.01% | 1091 |
|
|
2020
Q1 | $552K | Buy |
11,506
+501
| +5% | +$26K | 0.01% | 1301 |
|
|
2019
Q4 | $557K | Buy |
11,005
+711
| +7% | +$36.7K | ﹤0.01% | 1507 |
|
|
2019
Q3 | $486K | Buy |
10,294
+1,523
| +17% | +$69.5K | ﹤0.01% | 1516 |
|
|
2019
Q2 | $413K | Sell |
8,771
-5,215
| -37% | -$241K | ﹤0.01% | 1550 |
|
|
2019
Q1 | $673K | Buy |
13,986
+4,942
| +55% | +$248K | 0.01% | 1285 |
|
|
2018
Q4 | $403K | Sell |
9,044
-118
| -1% | -$6.15K | ﹤0.01% | 1440 |
|
|
2018
Q3 | $495K | Sell |
9,162
-163
| -2% | -$8.34K | ﹤0.01% | 1449 |
|
|
2018
Q2 | $455K | Sell |
9,325
-48,241
| -84% | -$2.74M | ﹤0.01% | 1450 |
|
|
2018
Q1 | $3.61M | Buy |
57,566
+47,030
| +446% | +$3.23M | 0.04% | 412 |
|
|
2017
Q4 | $646K | Sell |
10,536
-7,172
| -41% | -$443K | 0.01% | 1164 |
|
|
2017
Q3 | $1.19M | Sell |
17,708
-443
| -2% | -$31.3K | 0.02% | 768 |
|
|
2017
Q2 | $1.41M | Buy |
18,151
+1,388
| +8% | +$105K | 0.02% | 648 |
|
|
2017
Q1 | $1.37M | Buy |
16,763
+6,809
| +68% | +$536K | 0.02% | 601 |
|
|
2016
Q4 | $716K | Buy |
9,954
+394
| +4% | +$28.5K | 0.01% | 834 |
|
|
2016
Q3 | $743K | Buy |
9,560
+643
| +7% | +$52K | 0.01% | 822 |
|
|
2016
Q2 | $696K | Buy |
8,917
+42
| +0.5% | +$3.35K | 0.01% | 782 |
|
|
2016
Q1 | $727K | Buy |
8,875
+408
| +5% | +$33.2K | 0.02% | 707 |
|
|
2015
Q4 | $756K | Buy |
8,467
+2,290
| +37% | +$194K | 0.02% | 662 |
|
|
2015
Q3 | $475K | Buy |
6,177
+619
| +11% | +$51.7K | 0.01% | 776 |
|
|
2015
Q2 | $465K | Buy |
5,558
+861
| +18% | +$76K | 0.01% | 845 |
|
|
2015
Q1 | $424K | Sell |
4,697
-6,601
| -58% | -$568K | 0.01% | 876 |
|
|
2014
Q4 | $912K | Buy |
11,298
+139
| +1% | +$11K | 0.03% | 524 |
|
|
2014
Q3 | $836K | Buy |
11,159
+87
| +0.8% | +$6.33K | 0.02% | 583 |
|
|
2014
Q2 | $759K | Sell |
11,072
-823
| -7% | -$56K | 0.03% | 555 |
|
|
2014
Q1 | $832K | Sell |
11,895
-4,654
| -28% | -$324K | 0.03% | 487 |
|
|
2013
Q4 | $1.11M | Sell |
16,549
-368
| -2% | -$22.5K | 0.05% | 365 |
|
|
2013
Q3 | $882K | Sell |
16,917
-3,121
| -16% | -$159K | 0.04% | 409 |
|
|
2013
Q2 | $946K | Buy |
+20,038
| New | +$915K | 0.05% | 334 |
|
Other funds holding CAH
Cambridge Investment Research Advisors's CAH Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Cardinal Health (CAH) stake by 10% in Q2 2026, buying an estimated $1.32M and bringing the position to 69,165 shares worth $16.4M. The position accounts for 0.04% of the portfolio, ranked #485.
Cambridge Investment Research Advisors first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Cambridge Investment Research Advisors held 69,165 shares of Cardinal Health worth $16.4M as of Q2 2026.
- Cambridge Investment Research Advisors bought 6,366 Cardinal Health shares in Q2 2026, an estimated $1.32M.
- Cardinal Health made up 0.04% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #485 holding.
- Cambridge Investment Research Advisors first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.